Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × Ogivri × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 16 Anatomic Stage II Breast Cancer AJCC v8 2 Anatomic Stage I Breast Cancer AJCC v8 2 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Inflammatory Breast Neoplasms 1 Hodgkin Disease 1 Heart Failure 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Brain Neoplasms 1 Advanced Breast Carcinoma 1

Interventions

Carvedilol 2 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Trastuzumab 1 Specimen Handling 1 Secondary Prevention 1 Perindopril 1 Ogivri 1 Metoprolol 1 Exercise 1 Electronic Health Records 1 Echocardiography 1 Carnitine 1 Bisoprolol 1 Adrenergic beta-Antagonists 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡